Literature DB >> 29691085

The SMYD3 VNTR 3/3 polymorphism confers an increased risk and poor prognosis of hepatocellular carcinoma in a Chinese population.

Rui-Dong Li1, Yan-Hua Tang1, Hui-Li Wang2, Dong Yang1, Li-Jun Sun1, Wei Li1.   

Abstract

OBJECTIVE: Hepatocellular carcinoma (HCC) is one of the most lethal human malignancies in China, and the genetic link of hepatocarcinogenesis remains to be defined. Thus, we explored the role of SET and myeloid translocation protein 8, Nervy, and DEAF1 (MYND) domain containing protein 3 (SMYD3) gene polymorphism on risk and prognosis of HCC.
METHODS: A total of 236 patients with HCC who received treatment in Affiliated Hospital of Jining Medical University for the first time and 230 healthy individuals were enrolled in the study. After DNA extraction for all the subjects, polymerase chain reaction (PCR) was used to amplify and sequence variable numbers of tandem repeat (VNTR) loci of SMYD3 gene. SMYD3 gene was genotyped and its frequency distribution was calculated. Age, education level, income, smoking and drinking history, HCC family history, tumor node metastasis (TNM) staging, maximum tumor diameter, lymph node metastasis (LNM) etc. were investigated. Correlation of SMYD3 gene polymorphism and other risk factors with the occurrence and prognosis of HCC was analyzed.
RESULTS: The family history of HCC, drinking history, cirrhosis, and HBV or/and HCV infection, SMYD3 VNTR 3/3 were more frequently observed in subjects with HCC. Patients with SMYD3 VNTR 3/3 genotype, drinking-history, family history of HCC, cirrhosis and hepatitis B virus (HBV), TNM staging, maximum tumor diameter, LNM were more vulnerable to HCC. Besides, patients with SMYD3 VNTR 3/3 genotype had lower 2- and 3-year survival rate. The COX regression analysis revealed that drinking history, family history of HCC, SMYD3 VNTR 3/3 genotype, TNM staging, and LNM were all related to the prognosis of HCC.
CONCLUSION: This study indicates that drinking history, family history of HCC and SMYD3 VNTR 3/3, TNM staging, maximum tumor diameter, LNM might be risk factors for HCC, and SMYD3 VNTR 3/3 might contribute to a lower 2- and 3-year survival rate of patients with HCC.
Copyright © 2018. Published by Elsevier GmbH.

Entities:  

Keywords:  Cirrhosis; Drinking history; Family history of hepatocellular carcinoma; Hepatitis B virus; Hepatocellular carcinoma; Polymorphism; Risk factors; SMYD3 gene

Mesh:

Substances:

Year:  2018        PMID: 29691085     DOI: 10.1016/j.prp.2018.04.005

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  4 in total

1.  Osteosarcopenic obesity and its components-osteoporosis, sarcopenia, and obesity-are associated with blood cell count-derived inflammation indices in older Chinese people.

Authors:  Yi-Zhen Nie; Zhao-Qi Yan; Hui Yin; Ling-Han Shan; Jia-Hui Wang; Qun-Hong Wu
Journal:  BMC Geriatr       Date:  2022-06-28       Impact factor: 4.070

2.  A Novel lncRNA IHS Promotes Tumor Proliferation and Metastasis in HCC by Regulating the ERK- and AKT/GSK-3β-Signaling Pathways.

Authors:  Zheng Chen; Wei Yu; Qiming Zhou; Jianlong Zhang; Hai Jiang; Dake Hao; Jie Wang; Zhenyu Zhou; Chuanchao He; Zhiyu Xiao
Journal:  Mol Ther Nucleic Acids       Date:  2019-04-30

3.  Upregulation of SMYD3 and SMYD3 VNTR 3/3 polymorphism increase the risk of hepatocellular carcinoma.

Authors:  Mai Thanh Binh; Nghiem Xuan Hoan; Dao Phuong Giang; Hoang Van Tong; C-Thomas Bock; Heiner Wedemeyer; Nguyen Linh Toan; Mai Hong Bang; Peter G Kremsner; Christian G Meyer; Le Huu Song; Thirumalaisamy P Velavan
Journal:  Sci Rep       Date:  2020-02-18       Impact factor: 4.379

4.  SMYD3 promotes hepatocellular carcinoma progression by methylating S1PR1 promoters.

Authors:  Heyun Zhang; Zhangyu Zheng; Rongqin Zhang; Yongcong Yan; Yaorong Peng; Hua Ye; Lehang Lin; Junyao Xu; Wenbin Li; Pinbo Huang
Journal:  Cell Death Dis       Date:  2021-07-23       Impact factor: 8.469

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.